R W M Pharma Pvt Ltd - Complete Company Profile

R W M Pharma is a Private incorporated on 01-01-2010. It is classified as a Non-govt company and is registered at Registrar of Companies, Mumbai.

Its authorized share capital is ₹ 510,000,000 and its paid-up capital is ₹ 430,307,808. It is involved in other wholesale [Includes specialized wholesale not covered in any one of the previous categories and wholesale in a variety of goods without any particular specialization]

R W M Pharma Annual General Meeting (AGM) was last held on 15 February 2021 and as per records from the Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 31 March 2020.

Who is the Director of R W M Pharma

Private Limited?

Directors of R W M Pharma is Muzammil Rasool

 

R W M Pharma and its registration number are 47689 and its registered address is Ramdev Ritu Heights, Jamanlal Bajaj Road Opp. Regent Chambers Nariman Point Mumbai Mumbai, Maharashtra 400021

In order to contact R W M Pharma - Mail them at: 

support@rwmpharma.com

 

Website  

www.rwmpharma.com 

 

What is Pharmaceutical Industry?

The pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered (or self-administered) to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms.

In 2011, global spending on prescription drugs topped $954 billion, even as growth slowed somewhat in Europe and North America. The United States accounts for more than a third of the global pharmaceutical market, with $340 billion in annual sales followed by the EU and Japan.

Emerging markets such as China, Russia, South Korea, and Mexico outpaced that market, growing a huge 81 percent.

The top ten best-selling drugs of 2013 totaled $75.6 billion in sales, with the anti-inflammatory drug Humira being the best-selling drug worldwide at $10.7 billion in sales. The second and third best-selling were Enbrel and Remicade, respectively.

The top three best-selling drugs in the United States in 2013 were Abilify ($6.3 billion,) Nexium ($6 billion), and Humira ($5.4 billion).

The best-selling drug ever, Lipitor, averaged $13 billion annually and netted $141 billion total over its lifetime before Pfizer's patent expired in November 2011.

The current status of R W M Pharma is - Active.

CRUNCHBASE PROFILE: https://www.crunchbase.com/organization/r-w-m-pharma

INDIA MART PROFILE: https://www.indiamart.com/r-w-m-pharma/

Google : https://g.co/kgs/K4SG7Q